ArticleObesity surgery2025
Impact of Sleeve Gastrectomy on Ectopic Fat Deposition and Skeletal Muscle Composition Across Glucose Metabolic States.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus.Nature reviews. Gastroenterology & hepatology · 2026Review
- Preoperative Triglyceride-Glucose Index as a Predictor of Weight Loss Following Sleeve Gastrectomy: A Retrospective Cohort Study.Obesity surgery · 2026Article
- Metabolic Syndrome Modifies Changes in Body Composition After Sleeve Gastrectomy: A Quantitative CT Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDifferences in abdominal fat and muscle composition among patients with obesity across glycemic statuses-and the modulatory role of metabolic bariatric surgery (MBS) on these interrelationships-remain unclear. This study thus aims to elucidate the interplay between body composition and glycemic status, and to assess how MBS differentially impacts metabolic parameters and body composition outcomes in these patient groups.
methodsIn this single-center prospective study, 49 patients with obesity (31 with impaired glucose metabolism [IGM], 18 with normal glucose tolerance [NGT]) underwent Dixon MRI for fat/water separation to assess pancreatic, hepatic, and muscle fat. Measurements were taken preoperatively and 3 months post-laparoscopic sleeve gastrectomy.
resultsThe study included 18 patients with NGT (2 male/16 female; mean age 26.22 ± 7.17 years) and 31 with IGM (16 male/15 female; mean age 33.52 ± 10.65years). Both groups showed significant postoperative reductions in all measured parameters (P < 0.0001). The IGM group demonstrated greater decreases in visceral fat (88.33 ± 38.33 vs. 54.68 ± 25.91 cm
conclusionsPatients with obesity and IGM have higher visceral fat, pancreatic fat, and erector spinae mass than their NGT counterparts. Following bariatric surgery, they experience greater reductions in liver fat, pancreatic fat, and muscle areas. These findings suggest differential metabolic effects based on preoperative glucose status. However, further large-scale studies are needed to confirm.
Indexed as
Identifiers
40439964What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.